Aβ oligomers from human brain impair mossy fiber LTP in CA3 of hippocampus, but activating cAMP-PKA and cGMP-PKG prevents this

[1]  Yoav Ben-Simon,et al.  cAMP-Dependent Synaptic Plasticity at the Hippocampal Mossy Fiber Terminal , 2022, Frontiers in Synaptic Neuroscience.

[2]  D. Selkoe,et al.  An ultra‐sensitive immunoassay detects and quantifies soluble Aβ oligomers in human plasma , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[3]  M. Kennedy,et al.  Verubecestat for Prodromal Alzheimer's Disease. Reply. , 2019, The New England journal of medicine.

[4]  Elentina K. Argyrousi,et al.  Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade , 2019, Molecular Neurodegeneration.

[5]  Shaomin Li,et al.  Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer’s disease , 2018, Acta Neuropathologica Communications.

[6]  A. Palmeri,et al.  The effect of amyloid-β peptide on synaptic plasticity and memory is influenced by different isoforms, concentrations, and aggregation status , 2018, Neurobiology of Aging.

[7]  M. Frosch,et al.  Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer’s disease brain , 2018, Acta Neuropathologica.

[8]  W. Klein,et al.  A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid‐β oligomers , 2017, Journal of neurochemistry.

[9]  C. Mulle,et al.  PGE2-EP3 signaling pathway impairs hippocampal presynaptic long-term plasticity in a mouse model of Alzheimer's disease , 2017, Neurobiology of Aging.

[10]  Shaomin Li,et al.  Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate , 2017, The Journal of Neuroscience.

[11]  M. Rowan,et al.  Peripheral Interventions Enhancing Brain Glutamate Homeostasis Relieve Amyloid &bgr;- and TNF&agr;- Mediated Synaptic Plasticity Disruption in the Rat Hippocampus , 2016, Cerebral cortex.

[12]  Denise Manahan-Vaughan,et al.  β-Adrenergic Control of Hippocampal Function: Subserving the Choreography of Synaptic Information Storage and Memory , 2016, Cerebral cortex.

[13]  O. Arancio,et al.  Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach , 2015, Neurotherapeutics.

[14]  E. Rolls.  A quantitative theory of the functions of the hippocampal CA3 network in memory , 2013, Front. Cell. Neurosci..

[15]  J. Corbin,et al.  Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions. , 2011, Physiological reviews.

[16]  Richard Graham Knowles,et al.  GSK256066, an Exceptionally High-Affinity and Selective Inhibitor of Phosphodiesterase 4 Suitable for Administration by Inhalation: In Vitro, Kinetic, and In Vivo Characterization , 2011, Journal of Pharmacology and Experimental Therapeutics.

[17]  D. Selkoe,et al.  Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration , 2011, Proceedings of the National Academy of Sciences.

[18]  Matthew W. Jones,et al.  Altered synaptic plasticity in the mossy fibre pathway of transgenic mice expressing mutant amyloid precursor protein , 2010, Molecular Brain.

[19]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[20]  N. Lemon,et al.  Beta-adrenergic receptor activation during distinct patterns of stimulation critically modulates the PKA-dependence of LTP in the mouse hippocampus. , 2008, Learning & memory (Cold Spring Harbor, N.Y.).

[21]  Susumu Tonegawa,et al.  Transgenic Inhibition of Synaptic Transmission Reveals Role of CA3 Output in Hippocampal Learning , 2008, Science.

[22]  R. Kesner.  Behavioral functions of the CA3 subregion of the hippocampus. , 2007, Learning & memory.

[23]  J. Beavo,et al.  Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use , 2006, Pharmacological Reviews.

[24]  O. Vitolo,et al.  Ubiquitin Hydrolase Uch-L1 Rescues β-Amyloid-Induced Decreases in Synaptic Function and Contextual Memory , 2006, Cell.

[25]  Dietmar Schmitz,et al.  Synaptic plasticity at hippocampal mossy fibre synapses , 2005, Nature Reviews Neuroscience.

[26]  A. Palmeri,et al.  Amyloid-β Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP-Responsive Element-Binding Protein Pathway during Hippocampal Synaptic Plasticity , 2005, The Journal of Neuroscience.

[27]  R. Kesner,et al.  Differential contributions of dorsal hippocampal subregions to memory acquisition and retrieval in contextual fear‐conditioning , 2004, Hippocampus.

[28]  M. Quirk,et al.  Hippocampal CA3 NMDA Receptors Are Crucial for Memory Acquisition of One-Time Experience , 2003, Neuron.

[29]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[30]  O. Vitolo,et al.  Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Min,et al.  Change in bi‐directional plasticity at CA1 synapses in hippocampal slices taken from 6‐hydroxydopamine‐treated rats: the role of endogenous norepinephrine , 2002, The European journal of neuroscience.

[32]  G. Buzsáki,et al.  Single granule cells reliably discharge targets in the hippocampal CA3 network in vivo , 2002, Nature Neuroscience.

[33]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[34]  Brett Chromy,et al.  Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus , 2002, Brain Research.

[35]  C. Masters,et al.  Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.

[36]  L. Lue,et al.  Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .

[37]  E. Kandel,et al.  Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Paul Antoine Salin,et al.  Distinct short-term plasticity at two excitatory synapses in the hippocampus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  E. Kandel,et al.  Modulation of Both the Early and the Late Phase of Mossy Fiber LTP by the Activation of β-Adrenergic Receptors , 1996, Neuron.

[41]  D. Johnston,et al.  Noradrenergic enhancement of long-term potentiation at mossy fiber synapses in the hippocampus. , 1988, Journal of neurophysiology.